HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Sistema Silueta cellulite claims ban

This article was originally published in The Rose Sheet

Executive Summary

Sistema Silueta cellulite claims ban: U.S. District Court in California permanently bars Chatsworth, CA-based Silueta Distributors and its president, Stanley Klavir, from claiming that Sistema Silueta cream and tablets reduce cellulite, the Federal Trade Commission announces March 10. The ruling requires the defendants to pay $169,339 in customer refunds. The Feb. 24 court decision decreed the system "nothing more than moisturizer and diuretic tablets," according to FTC. The agency commenced a complaint against Silueta Distributors and Klavir on Nov. 22, 1993 ("The Rose Sheet" Nov. 29, 1993, p. 11), and received a court order temporarily prohibiting the cellulite claims July 11 ("The Rose Sheet" July 25, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001442

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel